Clinical Trials Directory

Trials / Completed

CompletedNCT07003204

Neutrophil-to Lymphocyte and Monocyte-to-Lymphocyte Ratios in Exudative Pleural Effusion

Diagnostic and Prognostic Role of Pleural Fluid Neutrophil-to Lymphocyte and Monocyte-to-Lymphocyte Ratios in Exudative Pleural Effusion

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Alexandria University · Academic / Other
Sex
All
Age
18 Months
Healthy volunteers
Not accepted

Summary

Exudative pleural effusion (EPE) presents a diagnostic challenge, requiring accurate biomarkers to predict outcomes and guide treatment. The neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-lymphocyte ratio (MLR) in pleural fluid are emerging as potential prognostic markers. We aimed to assess the diagnostic and prognostic utility of pleural fluid NLR and MLR in EPE.

Detailed description

Pleural fluid NLR and MLR are reliable biomarkers for diagnosing malignant pleural effusion and predicting poorer survival outcomes. These ratios may be useful in clinical practice, especially in resource-limited settings, to guide decision-making in the management of pleural effusions.

Conditions

Interventions

TypeNameDescription
PROCEDUREmedical thoracoscopypleural fluid aspiration and cellular analysis

Timeline

Start date
2025-05-11
Primary completion
2025-05-25
Completion
2025-05-26
First posted
2025-06-04
Last updated
2025-06-04

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07003204. Inclusion in this directory is not an endorsement.